The class of GLP-1 agonist drugs including Ozempic gained a wide reputation for weight loss in 2025. However, it's well established that weight regain is a common result after people stop their doses....Show More
🎉 Join the #1 community of podcast lovers and never miss a great podcast.
Sign up
Recommendations